FI962445A0 - Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi - Google Patents

Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi

Info

Publication number
FI962445A0
FI962445A0 FI962445A FI962445A FI962445A0 FI 962445 A0 FI962445 A0 FI 962445A0 FI 962445 A FI962445 A FI 962445A FI 962445 A FI962445 A FI 962445A FI 962445 A0 FI962445 A0 FI 962445A0
Authority
FI
Finland
Prior art keywords
preparation
paroxetine tablets
paroxetine
tablets
Prior art date
Application number
FI962445A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962445A7 (fi
FI962445L (fi
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI962445(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI962445A7 publication Critical patent/FI962445A7/fi
Publication of FI962445L publication Critical patent/FI962445L/fi
Publication of FI962445A0 publication Critical patent/FI962445A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962445A 1993-12-15 1996-06-12 Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi FI962445A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (3)

Publication Number Publication Date
FI962445A7 FI962445A7 (fi) 1996-06-12
FI962445L FI962445L (fi) 1996-06-12
FI962445A0 true FI962445A0 (fi) 1996-06-12

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962445A FI962445A0 (fi) 1993-12-15 1996-06-12 Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi

Country Status (35)

Country Link
US (1) US6113944A (cs)
EP (1) EP0734260B2 (cs)
JP (1) JP3037757B2 (cs)
KR (1) KR100367796B1 (cs)
CN (1) CN1071116C (cs)
AP (1) AP540A (cs)
AT (1) ATE180973T1 (cs)
AU (1) AU697982B2 (cs)
BG (1) BG62755B1 (cs)
BR (1) BR9408219A (cs)
CA (4) CA2214575C (cs)
CZ (1) CZ287891B6 (cs)
DE (1) DE69419033T2 (cs)
DK (1) DK0734260T4 (cs)
DZ (1) DZ1835A1 (cs)
ES (1) ES2132610T5 (cs)
FI (1) FI962445A0 (cs)
GB (1) GB9325644D0 (cs)
GR (1) GR3031047T3 (cs)
HU (1) HUT75880A (cs)
IL (1) IL111978A (cs)
MA (1) MA23395A1 (cs)
MY (1) MY112123A (cs)
NO (1) NO307366B1 (cs)
NZ (1) NZ277790A (cs)
OA (1) OA10297A (cs)
PL (1) PL314980A1 (cs)
RO (1) RO115413B1 (cs)
RU (1) RU2146141C1 (cs)
SA (1) SA94150373B1 (cs)
SI (1) SI0734260T2 (cs)
SK (1) SK282620B6 (cs)
UA (1) UA42745C2 (cs)
WO (1) WO1995016448A1 (cs)
ZA (1) ZA949900B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
ES2155995T3 (es) 1997-06-10 2001-06-01 Synthon Bv Compuestos de 4-fenilpiperidina.
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
AU5078700A (en) * 1999-06-22 2001-01-09 Smithkline Beecham Plc Novel composition
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
ATE352546T1 (de) 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram
EP1440067B1 (en) * 2001-10-22 2004-12-22 Synthon B.V. N-formyl derivatives of paroxetine
CA2470496A1 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
JP2008504263A (ja) * 2004-06-23 2008-02-14 メルク　エンド　カムパニー　インコーポレーテッド エストロゲン受容体モジュレーター
WO2006018318A1 (en) * 2004-08-18 2006-02-23 Synthon B.V. Liquid paroxetine compositions
EP1791531A1 (en) * 2004-08-20 2007-06-06 Alpharma, Inc. Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
CA2629514A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (cs) * 1974-03-04 1975-09-11
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
SA94150373A (ar) 2005-12-03
RU2146141C1 (ru) 2000-03-10
GR3031047T3 (en) 1999-12-31
AP540A (en) 1996-09-20
CA2214575A1 (en) 1995-06-22
SI0734260T2 (sl) 2008-12-31
EP0734260B1 (en) 1999-06-09
FI962445A7 (fi) 1996-06-12
NZ277790A (en) 1998-02-26
HK1012285A1 (en) 1999-07-30
NO307366B1 (no) 2000-03-27
NO962547L (no) 1996-06-14
ES2132610T5 (es) 2008-12-16
RO115413B1 (ro) 2000-02-28
DK0734260T4 (da) 2008-09-29
IL111978A0 (en) 1995-03-15
MA23395A1 (fr) 1995-07-01
CA2274387A1 (en) 1995-06-22
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
JPH09506602A (ja) 1997-06-30
BG62755B1 (bg) 2000-07-31
AP9400704A0 (en) 1995-01-31
CA2214575C (en) 1999-12-07
AU697982B2 (en) 1998-10-22
BG100648A (bg) 1997-02-28
FI962445L (fi) 1996-06-12
IL111978A (en) 2000-07-16
EP0734260A1 (en) 1996-10-02
GB9325644D0 (en) 1994-02-16
CN1137236A (zh) 1996-12-04
BR9408219A (pt) 1997-08-26
DE69419033D1 (de) 1999-07-15
CA2274389C (en) 2004-09-14
PL314980A1 (en) 1996-09-30
MY112123A (en) 2001-04-30
CA2178637C (en) 1997-12-23
DK0734260T3 (da) 1999-11-15
CN1071116C (zh) 2001-09-19
HU9601665D0 (en) 1996-08-28
NO962547D0 (no) 1996-06-14
AU1314595A (en) 1995-07-03
CZ287891B6 (cs) 2001-03-14
WO1995016448A1 (en) 1995-06-22
CA2274389A1 (en) 1995-06-22
CZ176396A3 (en) 1996-09-11
SA94150373B1 (ar) 2006-05-27
US6113944A (en) 2000-09-05
UA42745C2 (uk) 2001-11-15
ZA949900B (en) 1995-10-10
ES2132610T3 (es) 1999-08-16
ATE180973T1 (de) 1999-06-15
CA2178637A1 (en) 1995-06-22
DE69419033T2 (de) 1999-11-25
SI0734260T1 (sl) 1999-08-31
DZ1835A1 (fr) 2002-02-17
KR100367796B1 (ko) 2003-07-22
JP3037757B2 (ja) 2000-05-08
EP0734260B2 (en) 2008-07-09
SK282620B6 (sk) 2002-10-08
HUT75880A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
FI962445A0 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
DE69615552D1 (de) Pflanzenschutzmittel
FI941137A0 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI934440L (fi) Fibrintaeckmedelskompositioner och foerfaranden foer anvaendning av dem
FI945731A0 (fi) Tiatsolidiinijohdannaiset ja farmaseuttiset koostumukset, jotka sisältävät niitä
FI944978L (fi) Syklosporiinijohdannaista sisältävä farmaseuttinen koostumus
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
DE69603944D1 (de) Pflanzenschutzmittel
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
DE69613843D1 (de) Pflanzenschutzmitteln
FI944713A0 (fi) 4-difenyylimetyylipiperidiinijohdannaisia ja menetelmä niiden valmistamiseksi
HU9202864D0 (en) Gycinamide derivatives, their production and pharmaceutical preparatives containing them
NO952205D0 (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
IL117397A0 (en) Novel naphthyl pharmaceutical compounds
FI960316A0 (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI964229A0 (fi) Menetelmä doksorubisiinin valmistamiseksi
DK86492D0 (da) Laegemiddel
FI942046A0 (fi) Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi
FI932750A0 (fi) Kaoda nedbrytande svampar och preparation av dem
FI944751L (fi) Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
DK0794184T3 (da) 6-Methoxy-1H-benzotriazol-5-carboxamidderivater, fremgangsmåde til fremstilling deraf og lægemidler indeholdende dem
FI935715A0 (fi) Menetelmä sennosidien A ja B valmistamiseksi
FI924757A0 (fi) Foerfarande och anordning foer att effektivisera produktionen av byggnadsmaterial genom att utnyttja elektricitet
DK137192D0 (da) Laegemiddel/-plante
DK7190D0 (da) Laegemiddel

Legal Events

Date Code Title Description
FD Application lapsed